← Back
$DYN All transactions

Dyne Therapeutics, Inc.

A

$ Value

$0

Shares

85,000

Price

$0

Filed

Feb 17

Insider

Name

Kerr Douglas

Title

Chief Medical Officer

CIK

0001814189

Roles

Officer

Transaction Details

Transaction Date

2026-02-12

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

172,510

Footnotes

Consists of shares of Common Stock issuable under 85,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on May 12, 2026. | Includes 156,625 unvested RSUs. | This option was granted on February 12, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through February 12, 2030.

Filing Info

Accession No.

0001193125-26-055070

Form Type

4

Issuer CIK

0001818794

Kerr Douglas's History

Date Ticker Type Value
2026-03-05 DYN $13K
2026-02-12 DYN A $0
2026-02-12 DYN A $0
2025-12-05 DYN $18K
2025-09-05 DYN $12K
2025-09-04 DYN $47K
2025-07-16 DYN A $0
2025-06-05 DYN $18K

Other Insiders at DYN (90d)

Insider Bought Sold Last
Posner Brian S $118K 2026-03-30
Cox John
CEO & President
$41K 2026-03-05
Rhodes Jason P $16.5M 2026-04-22
Lucera Erick
Chief Financial Officer
$107K 2026-04-01
Kerr Douglas
Chief Medical Officer
$13K 2026-03-05
Kersten Dirk $24.7M 2026-04-22
Friedl-Naderer Johanna
Chief Commercial Officer
$2K 2026-03-05